SMI
11.990,27
PKT
+48,27
PKT
+0,40
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
19.06.17 | Nestlé overweight | JP Morgan Chase & Co. | |
19.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
16.06.17 | Nestlé overweight | Morgan Stanley | |
16.06.17 | Roche buy | Jefferies & Company Inc. | |
16.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
16.06.17 | Holcim buy | S&P Capital IQ | |
15.06.17 | Nestlé Underperform | Credit Suisse Group | |
15.06.17 | UBS Sell | S&P Capital IQ | |
15.06.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
15.06.17 | Nestlé buy | Goldman Sachs Group Inc. | |
15.06.17 | Nestlé buy | S&P Capital IQ | |
14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
13.06.17 | UBS overweight | Morgan Stanley | |
13.06.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
13.06.17 | Roche overweight | Barclays Capital | |
09.06.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
09.06.17 | Givaudan Hold | Deutsche Bank AG | |
09.06.17 | UBS Neutral | Goldman Sachs Group Inc. | |
09.06.17 | UBS buy | Goldman Sachs Group Inc. | |
08.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
08.06.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
08.06.17 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
08.06.17 | Swiss Re kaufen | Robert W. Baird & Co. Incorporated | |
07.06.17 | Roche overweight | JP Morgan Chase & Co. | |
07.06.17 | Swiss Re Outperform | Macquarie Research | |
07.06.17 | Nestlé Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
06.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
06.06.17 | Novartis Underweight | Morgan Stanley | |
06.06.17 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
06.06.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
06.06.17 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
06.06.17 | Roche buy | Deutsche Bank AG | |
06.06.17 | Roche Hold | Kepler Cheuvreux | |
06.06.17 | Roche Reduce | HSBC | |
02.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
02.06.17 | Novartis Underweight | Barclays Capital | |
02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
01.06.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
01.06.17 | Novartis buy | Jefferies & Company Inc. | |
26.05.17 | Nestlé buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.